Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2008-05-20
2008-05-20
Robinson, Hope (Department: 1652)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S350000, C435S006120, C435S007100
Reexamination Certificate
active
10777310
ABSTRACT:
Methods of eliciting a TLR8-mediated cellular response are disclosed. Such methods include administration of either a TLR8 agonist or a TLR8 antagonist to an IRM-responsive cell so that the IRM compound affects at least one TLR8-mediate cellular signaling pathway. In some cases, the method may provide prophylactic or therapeutic treatment for a condition treatable by modulating a TLR8-mediated cellular pathway.
REFERENCES:
patent: 4689338 (1987-08-01), Gerster
patent: 4698348 (1987-10-01), Gerster
patent: 4929624 (1990-05-01), Gerster et al.
patent: 4988815 (1991-01-01), Andre et al.
patent: 5037986 (1991-08-01), Gerster
patent: 5175296 (1992-12-01), Gerster
patent: 5238944 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster et al.
patent: 5268376 (1993-12-01), Gerster
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5367076 (1994-11-01), Gerster
patent: 5376501 (1994-12-01), Mariën et al.
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5395937 (1995-03-01), Nikolaides et al.
patent: 5446153 (1995-08-01), Lindstrom et al.
patent: 5482936 (1996-01-01), Lindstrom
patent: 5494916 (1996-02-01), Lindstrom et al.
patent: 5525612 (1996-06-01), Gerster
patent: 5605899 (1997-02-01), Gerster et al.
patent: 5693811 (1997-12-01), Lindstrom
patent: 5741908 (1998-04-01), Gerster et al.
patent: 5756747 (1998-05-01), Gerster
patent: 5939090 (1999-08-01), Beaurline et al.
patent: 6028076 (2000-02-01), Hirota et al.
patent: 6039969 (2000-03-01), Tomai et al.
patent: 6069149 (2000-05-01), Nanba et al.
patent: 6083505 (2000-07-01), Miller et al.
patent: 6110929 (2000-08-01), Gerster et al.
patent: 6113918 (2000-09-01), Johnson et al.
patent: 6194388 (2001-02-01), Krieg et al.
patent: 6194425 (2001-02-01), Gerster et al.
patent: 6200592 (2001-03-01), Tomai et al.
patent: 6207646 (2001-03-01), Krieg et al.
patent: 6239116 (2001-05-01), Krieg et al.
patent: 6245776 (2001-06-01), Skwierczynski et al.
patent: 6303347 (2001-10-01), Johnson et al.
patent: 6323200 (2001-11-01), Gerster et al.
patent: 6329381 (2001-12-01), Kurimoto et al.
patent: 6331539 (2001-12-01), Crooks et al.
patent: 6339068 (2002-01-01), Krieg et al.
patent: 6376501 (2002-04-01), Isobe et al.
patent: 6376669 (2002-04-01), Rice et al.
patent: 6387938 (2002-05-01), Mizuguchi et al.
patent: 6406705 (2002-06-01), Davis et al.
patent: 6426334 (2002-07-01), Agrawal et al.
patent: 6440992 (2002-08-01), Gerster et al.
patent: 6451810 (2002-09-01), Coleman et al.
patent: 6476000 (2002-11-01), Agrawal
patent: 6514985 (2003-02-01), Gerster et al.
patent: 6518265 (2003-02-01), Kato et al.
patent: 6518280 (2003-02-01), Gerster et al.
patent: 6525028 (2003-02-01), Johnson et al.
patent: 6525064 (2003-02-01), Dellaria et al.
patent: 6541485 (2003-04-01), Crooks et al.
patent: 6545016 (2003-04-01), Dellaria et al.
patent: 6545017 (2003-04-01), Dellaria et al.
patent: 6558951 (2003-05-01), Tomai et al.
patent: 6573273 (2003-06-01), Crooks et al.
patent: 6649172 (2003-11-01), Johnson
patent: 6656938 (2003-12-01), Crooks et al.
patent: 6660735 (2003-12-01), Crooks et al.
patent: 6660747 (2003-12-01), Crooks et al.
patent: 6664260 (2003-12-01), Charles et al.
patent: 6664264 (2003-12-01), Dellaria et al.
patent: 6664265 (2003-12-01), Crooks et al.
patent: 6667312 (2003-12-01), Bonk et al.
patent: 6670372 (2003-12-01), Charles et al.
patent: 6677347 (2004-01-01), Crooks et al.
patent: 6677348 (2004-01-01), Heppner et al.
patent: 6677349 (2004-01-01), Griesgraber
patent: 6683088 (2004-01-01), Crooks et al.
patent: 7179253 (2007-02-01), Graham et al.
patent: 2002/0016332 (2002-02-01), Slade
patent: 2002/0055517 (2002-05-01), Smith
patent: 2002/0058674 (2002-05-01), Hedenstrom et al.
patent: 2002/0110840 (2002-08-01), Tomai et al.
patent: 2003/0022302 (2003-01-01), Lewis et al.
patent: 2003/0133913 (2003-07-01), Tomai et al.
patent: 2003/0139364 (2003-07-01), Krieg et al.
patent: 2003/0144283 (2003-07-01), Coleman et al.
patent: 2003/0199461 (2003-10-01), Averett et al.
patent: 2004/0010007 (2004-01-01), Dellaria et al.
patent: 2004/0014779 (2004-01-01), Gorden et al.
patent: 2004/0023870 (2004-02-01), Dedera et al.
patent: 2004/0171086 (2004-09-01), Fink et al.
patent: 0 394 026 (1990-10-01), None
patent: 1 104 764 (2001-06-01), None
patent: 9-208584 (1997-08-01), None
patent: 11-80156 (1999-03-01), None
patent: 11-222432 (1999-08-01), None
patent: 2000-247884 (2000-09-01), None
patent: WO 00/47719 (2000-08-01), None
patent: WO 00/75304 (2000-12-01), None
patent: WO 00/76505 (2000-12-01), None
patent: WO 00/76518 (2000-12-01), None
patent: WO 01/74343 (2001-10-01), None
patent: WO 02/22809 (2002-03-01), None
patent: WO 02/36592 (2002-05-01), None
patent: WO 02/46188 (2002-06-01), None
patent: WO 02/46189 (2002-06-01), None
patent: WO 02/46190 (2002-06-01), None
patent: WO 02/46191 (2002-06-01), None
patent: WO 02/46192 (2002-06-01), None
patent: WO 02/46193 (2002-06-01), None
patent: WO 02/46194 (2002-06-01), None
patent: WO 02/46749 (2002-06-01), None
patent: WO 02/085905 (2002-10-01), None
patent: WO 02/102377 (2002-12-01), None
patent: WO 03/020889 (2003-03-01), None
patent: WO 03/043572 (2003-05-01), None
patent: WO 03/045391 (2003-06-01), None
patent: WO 03/089602 (2003-10-01), None
patent: WO 03/103584 (2003-12-01), None
Saunder et al. (Antimicrobial Agents and Chemotherapy, Dec. 2003, vol. 47, No. 12, pp. 3846-3852).
Gorden et al. (Journal of Immunology, 2005, vol. 174, pp. 1259-1268).
Dockrell et al. (J. of Antimicrobial Chemotherapy (2001), vol. 48, pp. 751-755).
Richarson (J. of Org. Chem., vol. 25, p. 2581, 1963).
Akira S. et al., “Recognition of pathogen-associated molecular patterns by TLR family”,Immunology Letters, 2003, vol. 85, pp. 85-95.
Ozinsky A. et al., “The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors”,Proc. Nat. Acad. Sci., Dec. 2000, vol. 97, No. 25, pp. 13766-13771.
Lee et al., “Saturated Fatty Acid Activates but Polyunsaturated Fatty Acid Inhibits Toll-like Receptor 2 Dimerized with Toll-like Receptor 6 or 1”,The Journal of Biological Chemistry, vol. 279, No. 17, pp. 16971-16979.
Fonteneau et al., “Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells”,Journal of Virology, vol. 78, No. 10, pp. 5223-5232.
Testerman, et al., “Cytokine Induction by the Immunomodulators Imiquimod and S-27609”,Journal of Leukocyte Biology, vol. 58, pp. 365-372, Sep. 1995.
Chollet, et al, “Development of a Topically Active Imiquimod Formulation”,Pharmaceutical Development and Technology, 4(1), pp. 35-43 (1999).
Brassard et al.; “Interferon-α as an immunotherapeutic protein”; Journal of Leukocyte Biology; vol. 71; Apr. 2002; pp. 565-581.
Izumi et al.; “1H-imidazo[4,5-c]quinoline Derivatives as Novel Potent TNF-α Suppressors: Synthesis and Structure-Activity Relationship of 1-, 2-and 4-Substituted 1H-imidazo[4,5-c]quinolines or 1H-imidazo[4,5-c]pyridines”;Bioorganic and Medicinal Chemistry, vol. 11, pp. 2541-2550 (2003).
Hornung et al., “Quantitative Expression of Toll-Like Receptor 1-10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1”, The Journal of Immunology, 2002, 168; pp. 4531-4537.
Hemmi et al., “Small anti-viral compounds activate immune cellsviathe TLR7 MyD88-dependent Signaling pathway”,Nature Immunology, vol. 3, No. 2; Feb. 2002; pp. 196-200.
Medzhitov, “Toll-Like Receptors and Innate Immunity”,Nature Reviews Immunology, vol. 1; Nov. 2001, pp. 135-145.
Jurk et al. “Human TLR7 and TLR8 independently confer responsiveness to the antiviral compound R-848”,Nature Immunology, Jun. 2002, vol. 3, No. 6; p. 1.
Akira et al., “Toll-like receptors: critical proteins linking innate and acquired immunity”,Nature Immunology, Aug. 2001, vol. 2, No. 8; pp
Gorden Keith B.
Qiu Xiaohong
Vasilakos John P.
3M Innovative Properties Company
Robinson Hope
LandOfFree
Methods and compositions related to IRM compounds and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions related to IRM compounds and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions related to IRM compounds and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3957920